Erratum: White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition (PLoS ONE (2013) 8:12 (e84802) DOI: 10.1371/journal.pone.0084802);White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Liu, Qinghai ^a   He, Shuhan ^a   Groysman, Leonid ^a   Shaked, David ^a   Russin, Jonathan ^a   Cen, Steven ^a   Mack, William J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN CIRCULUS ARTERIOSUS; BRAIN ISCHEMIA; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORPUS CALLOSUM; IMMUNOHISTOCHEMISTRY; MICROGLIA; MORTALITY; MOUSE; NONHUMAN; WHITE MATTER INJURY; ANIMAL; CEREBELLUM; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; VASCULARIZATION; WHITE MATTER;

ANIMALS; CAROTID STENOSIS; CEREBELLUM; COMPLEMENT C5; CORPUS CALLOSUM; MICE; MICE, MUTANT STRAINS; WHITE MATTER;

EID: 84893615997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094516     Document Type: Erratum

References (40)

1. de Groot JC, de Leeuw F-E, Oudkerk M, Hofman A, Jolles J et al. (2001) Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 56: 1539-1545. doi:10.1212/WNL.56.11.1539. PubMed: 11402112. (Pubitemid 32532267)
2. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC et al. (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234: 851-859. doi:10.1148/radiol. 2343040197. PubMed: 15734937.
3. Suemoto CK, Nitrini R, Grinberg LT, Ferretti RE, Farfel JM et al. (2011) Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries. Stroke 42: 3614-3615. doi:10.1161/STROKEAHA.111. 628156. PubMed: 21940957.
4. de la Torre JC (2004) Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26: 517-524. doi:10.1179/016164104225016254. PubMed: 15265269.
5. Duan W, Gui L, Zhou Z, Liu Y, Tian H et al. (2009) Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice. J Neurol Sci 285: 39-45. doi:10.1016/j.jns.2009.05.010. PubMed: 19524941.
6. Miki K, Ishibashi S, Sun L, Xu H, Ohashi W et al. (2009) Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res 87: 1270-1281. doi:10.1002/jnr.21925. PubMed: 18951530.
7. Brouns R, De Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495. doi:10.1016/j.clineuro.2009.04.001. PubMed: 19446389.
8. Sahu A, Sunyer JO, Moore WT, Sarrias MR, Soulika AM et al. (1998) Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol Res 17: 109-121. doi:10.1007/BF02786436. PubMed: 9479573. (Pubitemid 28072400)
9. Sunyer JO, Lambris JD (1998) Evolution and diversity of the complement system of poikilothermic vertebrates. Immunol Rev 166: 39-57. doi:10.1111/j.1600-065X.1998.tb01251.x. PubMed: 9914901. (Pubitemid 29008471)
10. Sunyer JO, Zarkadis IK, Lambris JD (1998) Complement diversity: a mechanism for generating immune diversity? Immunol Today 19: 519-523. doi:10.1016/S0167-5699(98)01341-3. PubMed: 9818547. (Pubitemid 28518031)
11. David L, Haviland JCH, Fleischer Daniel T, Wetsel Rick A (1991) Structure of the Murine Fifth Complement Component (C5) Gene: A LARGE, HIGHLY INTERRUPTED GENE WITH A VARIANT DONOR SPLICE SITE AND ORGANIZATIONAL HOMOLOGY WITH THE THIRD AND FOURTH COMPLEMENT COMPONENT GENES. J Biol Chem 266: 11818-11825. PubMed: 1711041.
12. Mulligan MS, Schmid E, Till GO, Hugli TE, Friedl HP et al. (1997) C5a-dependent up-regulation in vivo of lung vascular P-selectin. J Immunol 158: 1857-1861. PubMed: 9029126. (Pubitemid 127469544)
13. Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA (1996) Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 20: 1-9. doi:10.1007/BF01487740. PubMed: 8926043. (Pubitemid 26047744)
14. Biotechnology SC (2013) C5a/α (L-14): sc-21941. http://wwwscbtcom/datasheet-21941-c5a-alpha-l-14-antibodyhtml.
15. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35: 2598-2603. doi:10.1161/01.STR. 0000143725.19053.60. PubMed: 15472111.
16. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y et al. (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38: 2826-2832. doi:10.1161/STROKEAHA.107.490151. PubMed: 17761909. (Pubitemid 47494024)
17. Wakita H, Tomimoto H, Akiguchi I, Kimura J (1994) Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol 87: 484-492. doi:10.1007/BF00294175. PubMed: 8059601. (Pubitemid 24128976)
18. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion. Stroke 35: 2598-2603. doi:10.1161/01.STR. 0000143725.19053.60. PubMed: 15472111.
19. Ihara M, Tomimoto H, Kinoshita M, Oh J, Noda M et al. (2001) Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab 21: 828-834. PubMed: 11435795. (Pubitemid 32613537)
20. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H et al. (1996) Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 27: 2069-2074. doi:10.1161/01.STR.27.11.2069. PubMed: 8898818. (Pubitemid 26372583)
21. Rosenberg GA, Sullivan N, Esiri MM (2001) White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32: 1162-1168. doi:10.1161/01.STR.32.5.1162. PubMed: 11340226.
22. Masumura M, Hata R, Nagai Y, Sawada T (2001) Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci Res 39: 401-412. doi:10.1016/S0168-0102(01)00195-X. PubMed: 11274739. (Pubitemid 32215422)
23. Mack WJ, Ducruet AF, Hickman ZL, Zurica J, Starke RM et al. (2008) Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy. Acta Neurochir (Wien) 150: 779-784; discussion: 10.1007/s00701-008-1618-6. PubMed: 18574546.
24. Ducruet AF, Zacharia BE, Sosunov SA, Gigante PR, Yeh ML et al. (2012) Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke. PLOS ONE 7: 26. PubMed: 22761695.
25. Mack WJ, Sughrue ME, Ducruet AF, Mocco J, Sosunov SA et al. (2006) Temporal pattern of C1q deposition after transient focal cerebral ischemia. J Neurosci Res 83: 883-889. doi:10.1002/jnr.20775. PubMed: 16447284.
26. Pavlovski D, Thundyil J, Monk PN, Wetsel RA, Taylor SM et al. (2012) Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J 26: 3680-3690. doi:10.1096/fj. 11-202382. PubMed: 22651932.
27. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME et al. (2006) Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 99: 209-217. doi:10.1161/01.RES.0000232544.90675.42. PubMed: 16778128. (Pubitemid 44297045)
28. Kim GH, Mocco J, Hahn DK, Kellner CP, Komotar RJ et al. (2008) Protective effect of C5a receptor inhibition after murine reperfused stroke. Neurosurgery 63: 122-126; discussion: 18728577.
29. Ducruet AF, Hassid BG, Mack WJ, Sosunov SA, Otten ML et al. (2008) C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. J Cereb Blood Flow Metab 28: 1048-1058. doi:10.1038/sj.jcbfm.9600608. PubMed: 18197178. (Pubitemid 351589644)
30. Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ (1996) Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol 138: 22-32. doi:10.1006/exnr.1996.0043. PubMed: 8593893. (Pubitemid 26107986)
31. Zanjani H, Finch CE, Kemper C, Atkinson J, McKeel D et al. (2005) Complement activation in very early. Journal of Alzheimer'S Disease - Alzheimer Dis Assoc Disord 19: 55-66. doi:10.1097/01.wad.0000165506.60370.94. (Pubitemid 41073081)
32. Ager RR, Fonseca MI, Chu SH, Sanderson SD, Taylor SM et al. (2010) Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease. J Neurochem 113: 389-401. doi:10.1111/j.1471-4159.2010.06595.x. PubMed: 20132482.
33. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL et al. (1997) Molecular and cellular characterization of the membrane attack complex, C5b-9. Journal of Alzheimer'S Disease - Neurobiol Aging 18: 415-421. (Pubitemid 27436086)
34. Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD et al. (2009) Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol 183: 1375-1383. doi:10.4049/jimmunol.0901005. PubMed: 19561098.
35. Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S et al. (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187: 172-180. doi:10.4049/jimmunol.1100491. PubMed: 21642543.
36. del Zoppo GJ (2008) Virchow's triad: the vascular basis of cerebral injury. Rev Neurol DIS 5: S12-S21. PubMed: 18645567.
37. Rezkalla SH, Kloner RA (2002) No-Reflow Phenomenon. Circulation 105: 656-662. doi:10.1161/hc0502.102867. PubMed: 11827935. (Pubitemid 34123444)
38. Minkner K, Lovblad KO, Yilmaz H, Alimenti A, Sekoranja L et al. (2005) White matter lesions in watershed territories studied with MRI and parenchymography: a comparative study. Neuroradiology 47: 425-430. doi:10.1007/s00234-005-1358-8. PubMed: 15895219. (Pubitemid 41038859)
39. Wetsel RA, Fleischer DT, Haviland DL (1990) Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 265: 2435-2440. PubMed: 2303408.
40. Wheat WH, Wetsel R, Falus A, Tack BF, Strunk RC (1987) The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med 165: 1442-1447. doi:10.1084/jem. 165.5.1442. PubMed: 3572304.